Michael Martin Breen - Executive Chairman/Interim CEO, Director at GT Biopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Chairman/Interim CEO, Director
Stock Symbol
GTBP on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael Martin Breen since 8/27/2023

Holdings reported by Michael Martin Breen for GT Biopharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 856K $246K $0.29 Aug 11, 2023 Direct
Option to purchase Common Stock 500K Jan 27, 2023 Direct Common Stock

Transactions reported by Michael Martin Breen for GT Biopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.